Event Type
Disclosure
Mandatory
Variant
8-K
Entry into a Material Definitive Agreement. On February 24, 2026, Zura Bio Limited (the “ Company ’) entered into an underwriting agreement (the “ Underwriting
shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), or otherwise subject to the li
Other Events. On February 24, 2026, the Company issued a press release announcing the commencement of the Offering, a copy of which is filed as Exhibit 99.1 to
Financial Statements and Exhibits. (d) Exhibits Exhibit Number Exhibit Description 1.1* Underwriting Agreement, dated February 24, 2026, by and among the Compan